Antibiotic testing and screening system

The development of new antibiotics is an urgent priority. Antibiotic research often utilizes clinical drug-resistant strains to evaluate antimicrobial efficacy. However, the resistance mechanisms of clinical strains are often highly complex, making it difficult to assess the effectiveness of antibiotics against specific resistance mechanisms.
To address this issue, our company has developed an innovative antibiotic testing and screening platform using genetic engineering technology (*2017, Journal of Antimicrobial Chemotherapy*, 72, 3302-3316).